Case Report on Septicemia with Acute Kidney Injury

Shruti Moon^1*, Priya Rewatkar¹ and Aniket Pathade²

^*Correspondence: Shruti Moon, Florence Nightingale Training College of Nursing, Datta Meghe Institute of Medical Sciences (DU), India, Email:

Author info »

Introduction

Sepsis-associated acute kidney injury (S-AKI) is a common complication of critically ill individuals that is associated with unacceptably high morbidity and mortality. Because most people have S-AKI, it is difficult to prevent have already acquired acute kidney injury by the time they seek medical help. As a result, early detection is critical in order to give supportive therapy and limit additional harm. Acute kidney injury is difficult to detect early due to current diagnostic criteria; however, novel biomarkers of kidney stress and damage have recently been validated for risk prediction and early diagnosis of acute renal injury in sepsis. Microvascular dysfunction, inflammation, and metabolic reprogramming are all symptoms of metabolic reprogramming are three essential pathways that may influence the development of S-AKI , according to recent data. However, further mechanistic research is needed to better understand the complicated pathophysiology of S-AKI and to translate these findings into potential therapeutic techniques that will be added to the promising pharmacologic treatments now being developed and tested in clinical trials [1-3].

Acute kidney damage (AKI) is becoming increasingly common. Sepsis has long been recognized as a major cause of AKI. Critical sickness affects both children and adults, The high rate of morbidity and mortality associated with sepsis-associated AKI (SA-AKI) is predicted. SA-AKI is most likely a distinct subtype of AKI induced by a specific set of hemodynamic, inflammatory, and immunological mechanisms, despite our lack of understanding of its etiology. Clinicians have major clinical issues as a result of SA-AKI. To date, no one effective therapy for changing the natural history of SAAKI has been developed. Rather, contemporary attempts to improve Clinical risk assessment, early damage detection, changing medical behavior to avoid harm, and early appropriate antibiotic therapy are among the benefits, and long-term kidney damage surveillance among survivors. Patients are no longer killed by AKI, but by AKI, according to new findings. Clinicians require a strong understanding of SA-epidemiology AKI's and the most up-to-date best-evidence preventative and treatment options to enhance SA-AKI patient care and results [4-6].

A faulty host response to a systemic infection causes sepsis, a life-threatening organ failure. Acute kidney damage (AKI) is the leading cause of death in critically sick patients, especially in the unit of critical care (ICU). Despite advances in supportive care, the morbidity and Patients with sepsis-related AKI have a higher mortality rate (SA-AKI) remain significant. As a result, a thorough SA-AKI is well-understood is required not only for nephrologists, but also for other physicians, in order to improve awareness and proper management initiation. We cover a variety of subjects in SA-AKI in this chapter, including possible new therapy approaches [7-9].

Sepsis is caused by a dysregulated host response to infection, a dangerous medical illness. Despite breakthroughs in antibiotic therapy and life support, the mortality rate for individuals with sepsis has remained at or near 25%, and the disease is becoming more common. Sepsis is the most common cause of AKI in severely ill patients, which accounts for 50% or more of AKI cases in ICUs and has been related to an increased risk of death in the hospital. AKI was found in 22 percent of 192,980 patients with severe sepsis from seven US states, and it was linked to a 38.2% fatality rate. Detecting sepsisinduced AKI early will allow for appropriate and timely interventions, which may help to reduce the incidence of AKI significantly. Biomarkers, which have recently been developed in a variety of medical domains, including sepsis and AKI, may aid in the early detection of disease. However, focusing on sepsis-induced AKI biomarkers that have been used in clinical or experimental trials may allow us to better assess their utility. The accumulation of fluid and toxins in the body causes signs that your kidneys are no longer functioning properly. Although this isn't always the case, the most evident indicator is a decrease in the amount of urine produced. Although some people continue to generate urine, lab testing reveal that the urine is abnormal. As the fluid collects in the body's tissues, someone with acute kidney injury frequently appears puffy. Edema is a type of swelling that can develop quickly. Acute renal failure might also cause the following symptoms: Breathing problems Confusion Fatigue\nausea Seizures\s Coma. Many samples are taken throughout diagnosis and therapy because urine and blood tests inform doctors how well your kidneys are working. Doctors, for example, check for creatinine, which is produced when muscle breaks down. A BUN test (blood urea nitrogen) determines whether urea is building up in the blood, indicating that the kidneys are not properly filtering waste [10-12].

Patient specific information

A 22 -year-old male patient had been admitted to the hospital in AVBR hospital on date 21 /10/2021 with chief complaint patient presented with a c/o abdominal pain, fever, chills, for 4 days, c/o decreased appetite & generalized, weakness for 2 days, confused state for 1 day, nausea, vomiting, headache, fatigue, swelling, on hand & feet. Physical examination and investigation doctor diagnose a case of septicemia with acute kidney injury.

Primary concerns and symptoms of the patient

Chief complaint patient presented with a c/o abdominal pain, fever, chills, c/o decreased appetite & generalized, weakness, confused state, nausea, vomiting, headache, fatigue, swelling on hand & feet. Physical examination and investigations doctor diagnose a case of septicemia with acute kidney injury.

Medical, family and psycho-social history

There was no previous medical history of septicemia with acute kidney injury she took treatment for that in 22 /10/2021.

He belonged to nuclear family and there are four members in the family. All family members are healthy except the patient. Patient took fatigue, depressed. He had maintained good relationship with doctor and nurses as well as other patients also.

Relevant past intervention with outcomes

History of septicemia with acute kidney injury 2 month back for which he was hospitalized. After blood /urine tests, random blood sugar, creatinine, chlorine, potassium, etc. After investigations acute kidney injury observed he look treatment that of that in 22/10/2021 he was her outcomes was good.

Clinical findings

The patient was conscious and well oriented to date, time and place. Her body built was moderate and he had maintained good personal hygiene. Weight is 57kg her vital parameters are normal.

Timeline

2 months ago, he was admitted in the hospital for the treatment of septicemia with acute kidney injury treated with drug. He is currently being treated for acute kidney injury. Currently he was admitted for the treatment of acute kidney injury claims and multivitamin supplementary was given for 7 days. To enhance immune function.

Diagnostic assessment

Based on the patient history, physical examination, and investigations a complete blood count. Kidney function tests, urine test and testes to assess serum ammonia levels may be conducted. (MRI) and completed to myograph (CT) scans may also be performed during a physical examination of the belly or anus. Doctor often diagnose Ascites, dilated veins and other lab test X- rays and endoscopic examination can all be utilized to diagnose Septicemia with kidney injury diagnosis testing such as laboratory testing hemoglobin, random blood sugar tests all investigations are done.

Diagnostic challenges

No diagnostic challenges were faced.

Diagnostic

After physical examination and investigations doctor diagnose a case of acute kidney injury.

Prognosis

Was good.

Therapeutic intervention

Medical management was provided to the patient. Inj Piptaz, Inj Lasix, Inj Levoflox, Inj Pan, Inj Emset, Inj Norad infusion at BP, Inj vasopressin at BP, Inj Neomol stat , Inj D25% IV Stat. Her was took all treatment and outcomes was good.

Follow-up and outcomes

Clinical and patient assessment outcome

In spite of all care of patient progressed in active health of the patient after care of the patient regular medication healthy diet the will be recover and health status are improve more than before condition.

Discussion

A 22 -year-old male patient had been admitted to the hospital in AVBR hospital on date 21 /10/2021 with chief complaint patient presented with a c/o abdominal pain, fever, chills, for 4 days, c/o decreased appetite & generalized, weakness for 2 days, confused state for 1 day, nausea, vomiting, headache, fatigue, swelling, on hand & feet. Physical examination and investigation doctor diagnose a case of septicemia with acute kidney injury. Medical management was provided to the patient. Inj Piptaz, Inj Lasix, Inj Levoflox, Inj Pan, Inj Emset, Inj Norad infusion at BP, Inj vasopressin at BP, Inj Neomol stat, Inj D25% IV Stat. He was taking all treatment and outcomes are good. Sepsis is a severe and dysregulated inflammatory response to infection that is characterized by end-organ failure far from the infection's primary site. Sepsis-induced acute kidney damage (AKI) increases patient morbidity, predicts increased mortality, and has a significant impact on various organ functions, is linked to a longer Staying in the intensive care unit takes a lot of resources in the healthcare system. When compared to AKI caused by nonpeptic bacteria, septic AKI has a distinct pathogenesis that necessitates a different treatment strategy. Despite significant progress in various domains of medicine, the pathogenesis, diagnostic techniques, and suitable treatment strategies in sepsis remain controversial. When compared to other individuals who are critically ill, patients a number of immunomodulatory drugs that showed Preclinical investigations show promise, but they fail to reduce the excessively high death rate of sepsis and cause AKI. Limited histopathologic knowledge, a scarcity of animal models that accurately replicate human sepsis, and a scarcity of particular diagnostic techniques are all major roadblocks to advances in understanding, early identification, and use of effective therapy sepsis-induced AKI modalities Recent advances in our understanding of the fundamental processes that cause sepsis-induced AKI, as well as the next sections examine the characteristics of relevant animal models and potential therapies [13-15].

Purpose, although sepsis is frequently associated with acute kidney injury (AKI), the frequency with which sepsis arises as a consequence of AKI is unknown, as well as the clinical repercussions of this The causes of sepsis are unknown. The incidence of sepsis following AKI and the consequences related with it were investigated in this study. Methods, we looked at data from 618 critically sick patients who were part of a multicenter AKI trial (PICARD). Patients were placed into groups based on their symptoms on whether or not they had sepsis and when their sepsis occurred in relation to the diagnosis of AKI [15,16].

Because In critically unwell individuals, sepsis is the most prevalent cause of acute kidney injury (AKI), it's crucial to understand the structural changes that accompany it. As a result, we conducted a systematic literature review to examine current understanding on the histology of septic AKI. For all studies describing kidney histology in A comprehensive examination of the MEDLINE, EMBASE, and CINHAL databases on septic AKI, as well as the bibliographies of the retrieved papers, was conducted. There were only 184 individuals in six investigations that reported on the histology of septic AKI. Only 26 (22%) of the patients had characteristics that suggested tube necrosis (acute tubular necrosis) (ATN). There were four primate studies found. Seven of the 19 cases (37 percent) had ATN-like characteristics. In addition, we discovered 13 rodent studies of septic AKI. A total of 23% of the people tested positive for ATN. On histopathologic evaluation, there was no evidence of ATN in two subsequent experiments performed in a dog model and a sheep model. When ATN was absent, research found that septic AKI patients had a wide range of kidney morphologic alterations, ranging from normal (in most cases) to significant cortical tubular necrosis. In both human and experimental septic AKI, there are no consistent renal histological alterations. The majority of studies found that histology was normal or that there were very minor, nonspecific alterations. ATN was a rather rare condition [16].

Acute kidney injury (AKI) is a complicated condition for which there is currently no agreed-upon definition. We would be better able to manage these individuals if we had a standardized way of diagnosing and classifying AKI. Future clinical and translational research in AKI will necessitate multidisciplinary collaboration networks, information dissemination through multidisciplinary joint conferences and publications, and greater translation of knowledge from pre-clinical research. We discuss a project to create universal definitions and classifications for AKI, as well as a platform for interdisciplinary collaboration to improve care for patients with or at risk of AKI. In September 2005, members from prominent societies in critical care and nephrology, as well as additional experts in adult and pediatric AKI, attended a two-day meeting in Amsterdam, the Netherlands, and were allocated to one of three workgroups. The conversations in each group were used to develop draught recommendations, which were then revised and enhanced during talks with the wider group. There were also dissenting voices heard. All participants were given a copy of the final draught suggestions, which were then agreed upon as the consensus recommendations for this report. The proposals were approved by the participating societies, and they committed to help spread the findings. The proposals were approved by the participating societies, and they committed to help spread the findings. AKI is a name that has been proposed to include the complete range of acute renal failure. Acute changes in serum creatinine or urine output have been recommended as diagnostic criteria for AKI. A staging method for AKI has been established that takes into account variations in serum creatinine and urine output in terms of numbers. The creation of a It is termed a multidisciplinary collaborative network focusing on AKI a set of universal diagnostic and classification criteria for AKI, this will need to be tested further in the future. The Acute Kidney Injury Network provides a platform for improving patient outcomes in the future [17].

Conclusion

After AKI, sepsis is common and indicates a bad prognosis, with significant fatality rates and a relatively extended LOS. Future research should look into techniques for detecting and managing this issue in order to improve overall prognosis. Septic individuals have only been included in a few clinical investigations evaluating urine biomarkers in AKI. However, Certain biomarkers may aid in the early diagnosis of AKI in sepsis and may be effective in predicting future renal function decline, according to fascinating research. More prospective trials are needed to accurately explain their diagnostic and prognostic efficacy in septic AKI.

References

1. Peerapornratana S, Manrique-Caballero CL, Gómez H, et al. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 2019; 96:1083-1099.

Indexed at, Google scholar, Cross Ref

2. Alobaidi R, Basu RK, Goldstein SL, et al. Sepsis-associated acute kidney injury. Seminars Nephrol 2015; 35:2-11.

Indexed at, Google scholar, Cross Ref

3. Chancharoenthana W, Leelahavanichkul A, Eiam-Ong S. Sepsis-associated acute kidney injury. Sepsis 2017; 63.

Indexed at, Google scholar, Cross Ref

4. Alobaidi R, Basu RK, Goldstein SL, et al. Sepsis-associated acute kidney injury. Seminars Nephrol 2015; 35:2-11.
5. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol 2011; 22:999-1006.

Indexed at, Google scholar, Cross Ref

6. Mehta RL, Bouchard J, Soroko SB, et al. Sepsis as a cause and consequence of acute kidney injury: Program to improve care in acute renal disease. Intensive Care Med 2011; 37:241-248.

Indexed at, Google scholar, Cross Ref

7. Langenberg C, Bagshaw SM, May CN, et al. The histopathology of septic acute kidney injury: A systematic review. Crit Care 2008; 12:1-7.

Indexed at, Google scholar, Cross Ref

8. Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:1-8.

Indexed at, Google scholar, Cross Ref

9. Somani A, Hathi D, Acharya S, et al. Traumatic Rhabdomyolysis presenting as acute kidney injury and acute respiratory distress syndrome in young male athlete. Med Sci 2020; 24:771-775.

Google scholar

10. Sonawane S, Godhiwala P, Naik S, et al. Acute kidney injury masquerading as acute pancreatitis-role of serum amylase and lipase in patients with blunt abdominal trauma. J Evol Med Dent Sci 2020; 9:2767-2769.

Google scholar

11. Jain J, Banait S, Tiewsoh I, et al. Kikuchi's disease (histiocytic necrotizing lymphadenitis): A rare presentation with acute kidney injury, peripheral neuropathy, and aseptic meningitis with cutaneous involvement. Indian J Pathol Microbiol 2018; 61:113.

Indexed at, Google scholar, Cross Ref

12. Menasce LP, Banerjee SS, Edmondson D, et al. Histiocytic necrotizing lymphadenitis (Kikuchi–Fujimoto disease): Continuing diagnostic difficulties. Histopathol 1998; 33:248-254.

Indexed at, Google scholar, Cross Ref

13. Murray CJ, Abbafati C, Abbas KM, et al. Five insights from the global burden of disease study 2019. Lancet 2020; 396:1135-1159.

Indexed at, Google scholar, Cross Ref

14. Asghari B. Global burden of 369 diseases and injuries in 204 countries and territories, 1990 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396:1204-1222.

Indexed at, Google scholar, Cross Ref

15. Franklin RC, Peden AE, Hamilton EB, et al. The burden of unintentional drowning: global, regional and national estimates of mortality from the Global burden of disease 2017 study. Inj Prev 2020; 26:83-95.

Indexed at, Google scholar, Cross Ref

16. James SL, Castle CD, Dingels ZV, et al. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study. Inj Prev 2020; 26:125-153.

Indexed at, Google scholar, Cross Ref

17. James SL, Castle CD, Dingels ZV, et al. Global injury morbidity and mortality from 1990 to 2017: Results from the global burden of disease study 2017. Inj Prev 2020; 26:96-114.

Indexed at, Google scholar, Cross Ref